Skip to main content
. 2019 Oct 24;42(1):85–92. doi: 10.1002/hed.25986

Table 1.

Patient characteristics and treatment factors (n = 200)

Characteristics No. of patients (%)
Age (years)
Median 52
Range 19‐73
Sex
Male 147 (73.5)
Female 53 (26.5)
T classification
T3 80 (40.0)
T4 120 (60.0)
N classification
N0 22 (11.0)
N1 55 (27.5)
N2 107 (53.5)
N3 16 (8.0)
Stage
III 74 (37.0)
IVA/IVB 126 (63.0)
Prescription dose (Gy)
70 95 (47.5)
74 105 (52.5)
Chemotherapy
≤4 cycles 102 (51.0)
>4 cycles 98 (49.0)
Targeted therapy
Yes 34 (17.0)
No 210 (83.0)